bioAffinity Technologies (BIAF) Change in Accured Expenses (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Change in Accured Expenses of $310857.0 for Q1 2026, up 1210.72% year-over-year from $23716.5 in Q1 2025, and down 57.62% quarter-over-quarter from $733442.0 in Q4 2025.
bioAffinity Technologies (BIAF) Change in Accured Expenses (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Change in Accured Expenses for 6 consecutive years, with $310857.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 1210.72% year-over-year to $310857.0; the TTM figure through Mar 2026 stood at $658111.0 (up 35.02% YoY), while the FY2025 annual figure was $319267.0, up 28.27% from the prior year.
- Change in Accured Expenses eased to $310857.0 in Q1 2026 per BIAF's latest filing, from $733442.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $733442.0 in Q4 2025 and bottomed at -$339090.0 in Q3 2022.
- Historically, Change in Accured Expenses has averaged $98913.6 across 5 years, with a median of -$27987.0 in 2025.
- Annual changes were most pronounced in 2025 — Change in Accured Expenses plunged 476.22% — and 2026, when it surged 1210.72%.
- bioAffinity Technologies' Change in Accured Expenses stood at $442009.0 in 2022, then increased by 14.48% to $506025.0 in 2023, then retreated by 2.28% to $494470.0 in 2024, then jumped by 48.33% to $733442.0 in 2025, then sank by 57.62% to $310857.0 in 2026.
- Business Quant data shows BIAF's Change in Accured Expenses at $310857.0 in Q1 2026, $733442.0 in Q4 2025, and -$63487.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -249.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -48.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | - |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 12.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 23.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | - |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 142.00 Mn |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | 310,857.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 310,857.00 |
| Mar 31, 2026 | 310,857.00 |
| Dec 31, 2025 | 733,442.00 |
| Dec 31, 2025 | 733,442.00 |
| Sep 30, 2025 | -63,487.00 |
| Sep 30, 2025 | -63,487.00 |
| Jun 30, 2025 | -322,701.00 |
| Jun 30, 2025 | -322,701.00 |
| Mar 31, 2025 | -27,987.00 |
| Mar 31, 2025 | -27,987.00 |
| Dec 31, 2024 | 494,470.00 |
| Dec 31, 2024 | 494,470.00 |
| Sep 30, 2024 | -64,841.00 |
| Sep 30, 2024 | -64,841.00 |
| Jun 30, 2024 | 85,774.00 |
| Jun 30, 2024 | 85,774.00 |
| Mar 31, 2024 | -266,492.00 |
| Mar 31, 2024 | -266,492.00 |
| Dec 31, 2023 | 506,025.00 |
| Dec 31, 2023 | 506,025.00 |